SCHEMBL5200213

SCHEMBL5200213

Cc1cccc(-c2n[nH]cc2-c2ccc(F)c(-c3ccc(N4CCOCC4)cn3)c2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD9 Q9H8M2 1/20 0.38
BAZ2B Q9UIF8 1/20 0.38
MAP4K1 Q92918 2/20 0.38
TGFBR1 P36897 3/20 0.37
FYN P06241 1/20 0.36
LRRK2 Q5S007 5/20 0.36
THRB P10828 1/20 0.35
IL2 P60568 1/20 0.35
PIM1 P11309 1/20 0.35
TYK2 P29597 2/20 0.35
JAK2 O60674 1/20 0.35
JAK1 P23458 1/20 0.35
JAK3 P52333 1/20 0.35
PRKDC P78527 1/20 0.35
AHR P35869 1/20 0.35
TRPV3 Q8NET8 1/20 0.35
ITK Q08881 1/20 0.35
STK4 Q13043 2/20 0.35
STK3 Q13188 2/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5199926 0.90 MAP4K1 (0.42) MAP4K1TGFBR1THRBTYK2JAK2
SCHEMBL5200249 0.86 CNR1 (0.41) MAP4K1TGFBR1TYK2JAK2JAK1
SCHEMBL5199891 0.85 CNR2 (0.49) MAP4K1TGFBR1KDM4EALDH1A1MAPT
SCHEMBL5198175 0.84 BMPR1A (0.45) TGFBR1NPC1RAB9A
SCHEMBL5907460 0.82 TGFBR1 (0.43) BRD9BAZ2BTGFBR1PIM1AHR
SCHEMBL5198540 0.80 TGFBR1 (0.39) TGFBR1THRBTYK2JAK2JAK1
SCHEMBL5198641 0.80 TGFBR1 (0.37) BRD9BAZ2BTGFBR1
SCHEMBL5199757 0.79 JAK2 (0.42) TGFBR1TYK2JAK2JAK1JAK3
SCHEMBL5198168 0.78 TGFBR1 (0.41) TGFBR1THRB
SCHEMBL5199820 0.78 TGFBR1 (0.42) TGFBR1LRRK2THRBHCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275968-A1 Substituted Biphenyl Derivative SANKYO COMPANY, LIMITED (JP) 2007-11-29 US disclosed
EP-1798229-A1 SUBSTITUTED BIPHENYL DERIVATIVE Sankyo Company, Limited (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275968-A1 Substituted Biphenyl Derivative COL2A1, COL1A1, FGFR3 BRD9 376/4885BAZ2B 75/4885MAP4K1 4294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.